Literature DB >> 17265406

An outbreak of severe Clostridium difficile-associated disease possibly related to inappropriate antimicrobial therapy for community-acquired pneumonia.

Philip M Polgreen1, Yi Yi Chen, Joseph E Cavanaugh, Melissa Ward, Stacy Coffman, Douglas B Hornick, Daniel J Diekema, Loreen A Herwaldt.   

Abstract

We report a severe outbreak of Clostridium difficile infection. According to a chart review, half of the patients who received treatment for bacterial pneumonia before they developed C. difficile infection may not have had pneumonia. Excessive use of the hospital's new pneumonia care plan during the influenza season may have contributed to the intensity of this outbreak.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17265406     DOI: 10.1086/512174

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  12 in total

1.  Community-acquired pneumonia: 2012 history, mythology, and science.

Authors:  Gerald R Donowitz
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

2.  Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.

Authors:  Tamar F Barlam; Sara E Cosgrove; Lilian M Abbo; Conan MacDougall; Audrey N Schuetz; Edward J Septimus; Arjun Srinivasan; Timothy H Dellit; Yngve T Falck-Ytter; Neil O Fishman; Cindy W Hamilton; Timothy C Jenkins; Pamela A Lipsett; Preeti N Malani; Larissa S May; Gregory J Moran; Melinda M Neuhauser; Jason G Newland; Christopher A Ohl; Matthew H Samore; Susan K Seo; Kavita K Trivedi
Journal:  Clin Infect Dis       Date:  2016-04-13       Impact factor: 9.079

3.  Impact of an antibiotic restriction program on antibiotic utilization in the treatment of community-acquired pneumonia in a Veterans Affairs Medical Center.

Authors:  M D Mansouri; R M Cadle; S O Agbahiwe; D M Musher
Journal:  Infection       Date:  2011-02-12       Impact factor: 3.553

4.  Reporting hospitals' antibiotic timing in pneumonia: adverse consequences for patients?

Authors:  Mark W Friedberg; Ateev Mehrotra; Jeffrey A Linder
Journal:  Am J Manag Care       Date:  2009-02       Impact factor: 2.229

5.  When is an outbreak an outbreak? Using literature and discharge data to define Clostridioides difficile incidence changes referred to as outbreaks.

Authors:  C C Cohen; G Azhar; L Muggy
Journal:  J Hosp Infect       Date:  2020-03-20       Impact factor: 3.926

6.  Characterizing Risk Factors for Clostridioides difficile Infection among Hospitalized Patients with Community-Acquired Pneumonia.

Authors:  Caroline C Jozefczyk; W Justin Moore; Paul R Yarnold; Nathaniel J Rhodes; Karolina Harkabuz; Robert Maxwell; Sarah H Sutton; Christina Silkaitis; Chao Qi; Richard G Wunderink; Teresa R Zembower
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

7.  Impact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalizations: an analysis of the Nationwide Inpatient Sample.

Authors:  Monideepa B Becerra; Benjamin J Becerra; Jim E Banta; Nasia Safdar
Journal:  BMC Infect Dis       Date:  2015-07-01       Impact factor: 3.090

8.  Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy.

Authors:  Tiffany Kim; Sheetal Kandiah; Manish Patel; Saira Rab; Jordan Wong; Wenqiong Xue; Kirk Easley; Albert M Anderson
Journal:  BMC Res Notes       Date:  2015-10-17

Review 9.  Community-acquired pneumonia.

Authors:  Elena Prina; Otavio T Ranzani; Antoni Torres
Journal:  Lancet       Date:  2015-08-12       Impact factor: 79.321

10.  Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use.

Authors:  Chanu Rhee; Sameer S Kadri; John P Dekker; Robert L Danner; Huai-Chun Chen; David Fram; Fang Zhang; Rui Wang; Michael Klompas
Journal:  JAMA Netw Open       Date:  2020-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.